Emmanuel Chigutsa
Eli Lilly and Company
Dr Emmanuel Chigutsa is the head of the Pharmacometrics group at Eli Lilly and Company. The group applies pharmacokinetic-pharmacodynamic modeling and simulation-based methods in all phases of clinical drug development across various therapeutic areas including autoimmune, diabetes, oncology, neuroscience, COVID-19 among others. He received his PhD degree in Clinical Pharmacology from the University of Cape Town in 2013, a Masters in Pharmacogenetics from the University of Zimbabwe (UZ) and a Bachelor of Pharmacy degree from UZ in 2005. Dr Chigutsa is also an Adjunct Assistant Professor of Medicine at the Indiana University School of Medicine. Emmanuel Chigutsa, PhD | Group Leader, Pharmacometrics, Global PK/PD and Pharmacometrics, Eli Lilly and Company |
Appearances
DateMarch 25, 2022During a new pandemic such as COVID-19, there is a need to develop drug treatments as quickly as possible. However, a new disease means that limited information would be available…Speaker
Eli Lilly and CompanyFreeStandard Price
